medigraphic.com

2004, Number 1

<< Back Next >>

Rev Med Hosp Gen Mex 2004; 67 (1)

Pulmonary features in systemic lupus erythematosus. A brief review

Zambrano GJA, Rangel CCA, Novelo RV, Martínez-Cordero E

Language: Spanish
References: 38
Page: 41-49
PDF size: 627.99 Kb.


ABSTRACT

Pulmonary manifestations are frequent findings in systemic lupus erythematosus. The broad distribution of organ involvement which include the presence of several pleural, vascular and interstitial abnormalities may explain, at least in part, the diversity and heterogeneous appearance of lung disease in this autoimmune disorder. An accurate differential diagnosis by the clinician is essential to distinguish specific lung abnormalities during the study of this multisystemic disease. In particular, it is important to distinguish the respiratory changes that are related to the physiopathological mechanism of systemic lupus erythematosus from other abnormalities in which the autoimmune process did not play a significant role, like infectious disease of different etiology as well as hypersensitivity lung disease and interstitial pneumonitis. In addition to those lung complaints directly related to systemic lupus erythematosus, several reports emphasize the frequent appearance of respiratory abnormalities secondary to renal failure, heart disease and immunosuppressive treatment. Indeed, acute pneumonitis, pulmonary hypertension, thromboembolic disease, as well as lung hemorrhage and fibrosis may occur during the evolution of systemic lupus erythematosus, particularly in those patients who have severe complications. The aim of this review is emphasize though a case report, the relevance to establish a differential diagnosis of lung disease in systemic lupus erythematosus. It also pointed out that a well-organized multidisciplinary approach is important for studying the pulmonary manifestations in autoimmune multisystemic disorders.


REFERENCES

  1. McCarty DJ. Arthritis and allied conditions. Philadelphia: Lea & Febiger, 1989.

  2. Kelley WN, Harris ED, Ruddy S, Sledge CB. Textbook of rheumatology. Philadelphia: WB Saunders, 1985.

  3. Dickey BF, Myers AR. Pulmonary manifestations of colagen-vascular diseases. In: Fishman AP. Pulmonary diseases and disorders. New York: Mc Graw-Hill Book Company, 1988. pp. 645-666.

  4. Epler GR. Pulmonary manifestations of connective tissue disease. En Cohen AS. Rheumatology and Immunology. In: Dietschy JM. The science and practice of clinical medicine. New York: Grune and Stratton, 1979; 164-167.

  5. Turner-Warwick M. Immunology of the lung. London: Edward Arnold, 1978.

  6. Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989; 10: 677-721.

  7. Hunninghake GW, Fauci A. Pulmonary involvement in the collagen vascular diseases. Am Rev Resp Dis 1979; 119: 471-503.

  8. Sahan SA. Immunologic disease of the pleura. Clin Chest Med 1985; 6: 83-102.

  9. Ho Ch, Chian YM, Chong LL, Lin HY, Huang TS. Development of chronic lymphocytic leukaemia in a case of Sjögren’s syndrome with systemic lupus erythematosus. Scand J Haematol 1985; 35: 246-248.

  10. Cervera R, Khamashta MA, Font J, Hughes GR. European working party on systemic lupus erythematosus: a 10 year report. Lupus 2001; 10 (12): 892-4

  11. Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989; 10: 677-721.

  12. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849-853.

  13. Fishback N, Koss MN. Pulmonary involvement in systemic lupus erythematosus. Curr Opin Pulm Med 1995; 1: 368-375.

  14. Orens JB, Martinez FJ, Lynch JP III. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994; 20: 159-193.

  15. Good JT Jr, King TE, Antony VB, Sahn SA. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84: 714-718.

  16. Kaine JL. Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage. Ann Rheum Dis 1985; 44: 61-64.

  17. Carr DT, Lillington GA, Mayne JG. Pleural-fluid glucose in systemic lupus erythematosus. Mayo Clin Proc 1970; 45: 409-412.

  18. Lillington GA, Carr DT, Mayne JG. Rheumatoid pleurisy with effusion. Arch Intern Med 1971; 128: 764-768.

  19. Khare V, Baethge B, Lang S, Wolf RE, Campbell GD Jr. Antinuclear antibodies in pleural fluid. Chest 1994; 106: 866-871.

  20. Pertschuk LP, Moccia LF, Rosen Y, Lyons H, Marino CM, Rashford AA et al. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1977; 68: 553-557.

  21. Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erithematosus. J Thorac Imag 1992; 7:1-18.

  22. Murin S, Wiedeman HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998; 19: 641-665.

  23. Carette S, Macher AM, Nussbaum A, Plotz PH. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: Ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984; 14: 52-59.

  24. Urman JD, Rothfield NF. Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA 1977; 238: 2272-2276.

  25. Churg A, Franklin W, Chan KL, Kopp E, Carrington CB. Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus. Arch Pathol Lab Med 1980; 104: 388-391.

  26. Matthay RA, Hudson LD, Petty TL. Acute lupus pneumonitis: response to azathioprine therapy. Chest 1973; 63: 117-120.

  27. Carette S. Cardiopulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 130-147.

  28. Brasington RD, Furst DE. Pulmonary disease in systemic lupus erythematosus. Clin Exp Rheumatol 1985; 3: 269-276.

  29. Pines A, Kaplinsky N, Olchovsky D, Rosenman J, Frankcl O. Pleuropulmonary manifestations of systemic lupus erythematosus. Clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985; 88: 129-229.

  30. Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 1983; 74: 201-205.

  31. Hedgpeth MT, Boulware DW. Interstitial pneumonitis in antinuclear antibody negative systemic lupus erythematosus. A new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthritis Rheum 1988; 31: 545-548.

  32. Martínez-Cordero E, Martínez-Miranda E, Negrete-García MC, Padilla A. AntidsDNA and Sm autoantibodies in systemic lupus erythematosus. Clin Rheum 1992; 11: 341-345.

  33. Weinrib L, Sharma OP, Quismorio FP. A long-term study of interstitial lung disease in systemic lupus erythematosus. Sem Arthritis Rheum 1990; 20: 48-56.

  34. Howe HS, Boey ML, Fong KY, Feng PH. Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 1988; 47: 869-872.

  35. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Am J Med 1981; 71: 791-797.

  36. Inoue T, Kanayama Y, Ohe A, Kato N, Horiguchi T, Ishii M et al. Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann Intern Med 1979; 91: 30-34.

  37. Abud-Mendoza C, Diaz-Jouanen E, Alarcón-Segovia D: Fatal pulmonary hemorrhage in systemic lupus erythematosus. Occurrence without hemoptysis. J Rheumatol 1985; 12: 558.

  38. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-1315.




2020     |     www.medigraphic.com